All Articles by Author:

mladbrook

Phenotypic Heterogeneity Driven by Plasticity of the Intermediate EMT State Governs Disease Progression and Metastasis in Breast Cancer

[Science Advances] Investigators isolated multiple distinct single-cell clones from the SUM149PT human breast cell line spanning the epithelial-to-mesenchymal transition spectrum having diverse migratory, tumor-initiating, and metastatic qualities, including three unique intermediates.

Triple-Negative Breast Cancer Metastasis Involves Complex Epithelial-Mesenchymal Transition Dynamics and Requires Vimentin

[Science Translational Medicine] The authors demonstrated that spontaneous triple-negative breast cancer tumors from a genetically engineered mouse model, multiple patient-derived xenografts, and archival patient samples exhibited large populations in vivo of hybrid E/M cells that lead invasion ex vivo while expressing both epithelial and mesenchymal characteristics.

CircPDSS1 Promotes the Proliferation, Invasion, Migration, and EMT of Breast Cancer Cell via Regulating miR-320c/CKAP5 Axis

[Cancer Cell International] CircPDSS1 was upregulated in BC cells, and circPDSS1 knockdown repressed BC cell malignant behaviors.

Detection and Spatiotemporal Analysis of In Vitro 3D Migratory Triple-Negative Breast Cancer Cells

[Annals of Biomedical Engineering] Scientists present an image processing and segmentation pipeline for the detection of 3D GFP-fluorescent triple-negative breast cancer cell nuclei, and they performed quantitative analysis of the formed spatial patterns and their temporal evolution.

Dysregulation of Splicing Variants and Spliceosome Components in Breast Cancer

[Endocrine-Related Cancer] Investigators compile the current knowledge demonstrating the altered expression of splicing variants and spliceosomal components in BCa, showing the existence of a growing body of evidence supporting the close implication of the alteration in the splicing process in mammary tumorigenesis.

Glucose Deprivation Reduces Proliferation and Motility, and Enhances the Anti-Proliferative Effects of Paclitaxel and Doxorubicin in Breast Cell Lines In Vitro

[PLoS One] Scientists examined the effect of glucose as well as its deprivation, and antagonism using the non-metabolized analogue 2-deoxy glucose, on the proliferation of several breast cancer cell lines MCF7, MDA-MB-231, YS1.2 and pII and one normal breast cell line, using the MTT assay.

Popular

PlexinD1 Is a Driver and a Therapeutic Target in Advanced Prostate Cancer

[EMBO Molecular Medicine] Scientists identified the axon guidance semaphorin receptor PlexinD1 as a crucial driver of cancer aggressiveness in metastatic CRPC. High PlexinD1 expression in human prostate cancer was correlated with adverse clinical outcomes.

MICAL2 Promotes Pancreatic Cancer Growth and Metastasis

[Cancer Research] The authors highlighted the multiple ways in which MICAL2 impacted PDAC biology and provided a foundation for future investigations into the potential of targeting MICAL2 for therapeutic intervention.

KRASG12C-Mutated Nonsmall-Cell Lung Cancer: A Phase IIb Trial

[Nature Medicine] This multicenter, single-arm , Phase IIb study assessed the efficacy and safety of glecirasib administered orally at 800 mg daily in patients with locally advanced or metastatic KRASG12C-mutated NSCLC.